Sara Jane Demy, CEO, Demy-Colton, introducing a fireside chat in July, 2018
Discussion leaders from an array of disciplines facilitate the conversations which range from high-level problems shared with the group to specific issues that arise during organizational growth, such as going through an IPO or dealing with a clinical trial failure.
According to Brandi Simpson, CEO, Navigen, "The dialogue is open and honest, and the environment and program foster camaraderie and the development of strong relationships." Everyone participates in discussions and information sharing which essentially make the Demy-Colton CEO Summits mini think-tanks. Everyone comes away not only with new insights, but an expanded network of trusted individuals they can continue reaching out to.
Cynthia Collins, Interim CEO, Editas Medicine, said, “I made some great connections through my participation and have established meaningful and lasting relationships, both professionally and personally.”
A recurring thread in the exit surveys is that being a biotech CEO can be isolating, and the Summits bring together people that know what a biotech CEO goes through.
The locations for the current Summits - Napa in the US, and Enniskerry in Ireland -- were chosen because they are exclusive, beautiful, and secluded venues. While outsiders have tried to get a glimpse of the action, the Demy-Colton team works hard to ensure that they are private and free of distractions.
Edwin Moses adds this evaluation. “There's no other CEO forum like it in our industry.”
Demy-Colton is always looking to invite outstanding CEOs to participate in the Summits.
If you would like to participate in either the US or European Summit, please contact our Chief Business Officer, Lila Taylor at Ltaylor@demy-colton.com.